| Lindsey Hysmith, CRNA | |
|
1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129-2567 | |
| (615) 396-4464 | |
| (615) 396-6748 |
| Full Name | Lindsey Hysmith |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 1800 Medical Center Pkwy, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114321023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 169352 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas Rutherford Hospital | Murfreesboro, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Murfreesboro Anesthesia Group, P.a. | 9335038868 | 55 |
News Archive
The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
As its name suggests, inflammatory bowel disease, which afflicts more than 1.6 million Americans, involves chronic inflammation of all or some of the digestive tract. An autoimmune disease known to have a strong genetic component, its symptoms are abdominal cramps, bloody diarrhea, and fever and, sometimes, weight loss. IBD, which is a group of inflammatory conditions, includes Crohn's disease and ulcerative colitis.
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
› Verified 2 days ago
| Entity Name | Murfreesboro Anesthesia Group, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912959867 PECOS PAC ID: 9335038868 Enrollment ID: O20040312001032 |
News Archive
The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
As its name suggests, inflammatory bowel disease, which afflicts more than 1.6 million Americans, involves chronic inflammation of all or some of the digestive tract. An autoimmune disease known to have a strong genetic component, its symptoms are abdominal cramps, bloody diarrhea, and fever and, sometimes, weight loss. IBD, which is a group of inflammatory conditions, includes Crohn's disease and ulcerative colitis.
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Hysmith, CRNA Po Box 1252, Murfreesboro, TN 37133-1252 Ph: (615) 396-4464 | Lindsey Hysmith, CRNA 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129-2567 Ph: (615) 396-4464 |
News Archive
The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
As its name suggests, inflammatory bowel disease, which afflicts more than 1.6 million Americans, involves chronic inflammation of all or some of the digestive tract. An autoimmune disease known to have a strong genetic component, its symptoms are abdominal cramps, bloody diarrhea, and fever and, sometimes, weight loss. IBD, which is a group of inflammatory conditions, includes Crohn's disease and ulcerative colitis.
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
› Verified 2 days ago
John Benjamin Simpson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Carla Marie Marston, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Vanessa R Schulz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Ms. Letha Calvin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Janine Mclaughlin, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Zachery Charles Nichols, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Timothy F Pogue, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 |